Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Der Pathologe|May 4, 2019
[Pediatric tumors with spindle cell morphology]C Vokuhl
Der Pathologe|July 25, 2019
[Rare childhood kidney tumors]C Vokuhl
Pathologie (Heidelberg, Germany)|October 2, 2024
[Pediatric soft tissue tumors : Tumors of uncertain origin]K Greimelmaier, C Vokuhl
Pathologie (Heidelberg, Germany)|January 28, 2026
[Rare benign tumors/lesions in the head of children]E Jüttner, C Vokuhl
Der Pathologe|August 22, 2015
[Histiocytic diseases in childhood and adolescence]C Vokuhl, I Oschlies, W Klapper, et al.
ESMO Open|April 24, 2024
Therapeutic benefit of larotrectinib over the historical standard of care in patients with locally advanced or metastatic infantile fibrosarcoma (EPI VITRAKVI study)D Orbach, M Carton, S K Khadir, et al.
Leukemia|June 25, 2015
Effects of p38α/β inhibition on acute lymphoblastic leukemia proliferation and survival in vivoA Alsadeq, S Strube, S Krause, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2019
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2020
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.
Pageof 1